PLA2R1 and breast cancer: Although the HER2-positive, luminal A and luminal B subtypes of breast cancer demonstrated lower expression of PLA2R1 mRNA with median fold changes (0.029, 0.232 and 0.158, respectively), none of these differences approached statistical significance.